教育中心 >> 预读材料
-
Clinical Efficacy and Safety of Alirocumab after Acute Coronary Syndrome According to Achieved Level of Low-Density Lipoprotein Cholesterol: A Propensity Score-Matched Analysis of the ODYSSEY OUTCOMES TrialJOURNAL：Circulation.
-
Improvement of Clinical Outcome in Patients With ST-Elevation Myocardial Infarction Between 1999 And 2016 in China : The Prospective, Multicenter Registry MOODY StudyJOURNAL：Eur J Clin Invest.
-
Quantitative angiography methods for bifurcation lesions: a consensus statement update from the European Bifurcation ClubJOURNAL：EuroIntervention.
-
Pulmonary Artery Pressure-Guided Management of Patients With Heart Failure and Reduced Ejection FractionJOURNAL：J Am Coll Cardiol.
-
Association of Silent Myocardial Infarction and Sudden Cardiac DeathJOURNAL：JAMA Cardiol.
-
1-Year Outcomes of Delayed Versus Immediate Intervention in Patients With Transient ST-Segment Elevation Myocardial InfarctionJOURNAL：JACC Cardiovasc Interv.
-
Radial versus femoral access and bivalirudin versus unfractionated heparin in invasively managed patients with acute coronary syndrome (MATRIX): final 1-year results of a multicentre, randomised controlled trialJOURNAL：Lancet.
-
Reduced risk of gastrointestinal bleeding associated with proton pump inhibitor therapy in patients treated with dual antiplatelet therapy after myocardial infarctionJOURNAL：Eur Heart J.
-
Revascularization Strategies in STEMI with Multivessel Disease: Deciding on Culprit Versus Complete-Ad Hoc or StagedJOURNAL：Curr Cardiol Rep.
-
MR-proADM as a Prognostic Marker in Patients With ST-Segment-Elevation Myocardial Infarction-DANAMI-3 (a Danish Study of Optimal Acute Treatment of Patients With STEMI) SubstudyJOURNAL：J Am Heart Assoc.
http://www.cbsmd.cn Contact us by cbs@cbsmd.cn
Copyright ⓒ CBSMD Nanjing China. All rights reserved.
